ERBB2 and Charcot-Marie-Tooth disease: Further targets of those analyzed herein have also been investigated in CMT such as TP53 [21,22], PTEN [23,24,25,26,27], PFDN5 [15,26], MYC [27], HER2 [28], and MCL1 [29] associating their expression patterns with the development of CMT.